EOLS

Evolus (EOLS)

Evolus Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EOLS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	07 : 55	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/05/10	22 : 10	Business Wire	Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year	NASDAQ:EOLS	Evolus Inc
2024/05/08	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EOLS	Evolus Inc
2024/05/08	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EOLS	Evolus Inc
2024/05/08	05 : 05	Business Wire	Evolus Reports First Quarter 2024 Results and Provides Business Update	NASDAQ:EOLS	Evolus Inc
2024/04/24	05 : 30	Business Wire	Evolus to Report First Quarter Financial Results on May 7, 2024	NASDAQ:EOLS	Evolus Inc
2024/04/18	05 : 05	Business Wire	Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®	NASDAQ:EOLS	Evolus Inc
2024/04/13	05 : 05	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/03/26	21 : 00	Business Wire	Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:EOLS	Evolus Inc
2024/03/11	22 : 00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EOLS	Evolus Inc
2024/03/11	20 : 00	Business Wire	Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock	NASDAQ:EOLS	Evolus Inc
2024/03/09	06 : 05	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/03/08	06 : 58	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EOLS	Evolus Inc
2024/03/08	06 : 42	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:EOLS	Evolus Inc
2024/03/08	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EOLS	Evolus Inc
2024/03/08	06 : 05	Business Wire	Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance	NASDAQ:EOLS	Evolus Inc
2024/03/01	22 : 30	Business Wire	Evolus Announces Results from European Head-to-Head Filler Trial	NASDAQ:EOLS	Evolus Inc
2024/02/27	22 : 30	Business Wire	Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences	NASDAQ:EOLS	Evolus Inc
2024/02/24	10 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/24	10 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/23	06 : 30	Business Wire	Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	08 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/02/10	06 : 05	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/02/03	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/01/31	06 : 09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc